Market News AIOpen the app

MRKR stock news · Marker Therapeutics, Inc.

Stories about Marker Therapeutics, Inc. (MRKR) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for MRKR

Follow Marker Therapeutics, Inc. (MRKR) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for MRKR
Free on the App Store and Google Play, or on the web.
  1. Oct 19, 2026, 7:16 AM ET · Trial

    Marker Therapeutics, Inc. says it got a $2.6 million grant from the FDA for its MT-601 cancer treatment.

    Good for MRKR

    Marker Therapeutics won a $2.6 million FDA grant to advance its lead cell therapy for pancreatic cancer. The award supports its development work, making the news favorable for the company.

  2. Oct 16, 2026, 1:31 PM ET · Market

    12 health care stocks are changing a lot during Friday's trading.

    Neutral

    Marker Therapeutics shares rose 21.2% to $1.11, but the article gives no business news behind the move. It does not change the company's outlook.